Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Scientists probe blood immune clues in common Dandruff-Like skin condition

NCT ID NCT07297446

Knowledge-focused Sponsor: San Gallicano Dermatological Institute IRCCS Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at immune cells in the blood of 15 adults with seborrheic dermatitis (a chronic, flaky skin condition) and 15 healthy people. Researchers measured different types of immune cells and chemicals to see if there are differences between the two groups. They also asked about diet to explore possible links. This is a small pilot study meant to gather information for future research, not to test a treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

30 people

The number who actually took part.

Started

Jun 2024

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population will consist of people affected by SD (Seborrheic Dermatitis), both female and male, aged between 45 and 75 years, and healthy subjects selected from personnel undergoing routine examinations by the IFO Occupational Health Unit (Medicina del Lavoro IFO) and among members, friends, and relatives of the personnel of the Cutaneous Physiopathology Unit (UOC Fisiopatologia Cutanea).

Ages

45 to 75 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients affected by Facial Seborrheic Dermatitis (SD) of mild to moderate severity; other sebaceous areas of the body may also be affected. Both sexes. Age 45-75 years. Treatments for SD, topical and/or systemic, suspended for at least two (2) weeks. Willingness to comply with the appointments/procedures required by the study. Signature of the informed consent. Exclusion Criteria: * Concomitant dermatological conditions, such as, for example, atopic dermatitis, rosacea, acne, psoriasis, besides the inclusion condition (Seborrheic Dermatitis). Diagnosed neurodegenerative diseases. Ongoing pharmacological treatment, topical or systemic, for Seborrheic Dermatitis (SD). Immunosuppression. HIV seropositivity.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Dietary habits are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Feeding Behavior seborrheic dermatitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Dietary habits Seborrheic dermatitis

Contacts and locations

Locations

  • San Gallicano Dermatological Institute IRCCS

    Roma, Italy, 00144, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.